Basecamp Research
Private Company
Total funding raised: $3.5M
Overview
Basecamp Research operates at the intersection of biodiversity, genomics, and artificial intelligence, building a foundational atlas of the planet's protein diversity to power discovery. The company's core technology involves collecting and sequencing genetic material from diverse ecosystems worldwide and using proprietary AI models to predict novel, high-value protein functions for sectors like industrial biotech, agriculture, and therapeutics. As a private, likely pre-revenue platform company, it positions itself as a data and IP generator, aiming to become a key enabler for the bio-economy by providing access to nature-optimized molecular solutions that are difficult to find through traditional methods.
Technology Platform
Integrated platform combining global biodiversity sampling (eDNA collection under Nagoya Protocol), high-throughput genomics, and proprietary AI/ML models to discover and predict novel protein functions from natural sequence data.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Basecamp competes with other AI-native protein design firms (e.g., Absci, Generate Biomedicines) and large biopharma internal efforts. Its key differentiator is a first-principles focus on building a proprietary foundational dataset from global biodiversity, rather than relying primarily on public data or purely generative models.